MICROBOT MEDICAL INC. - COMMON STOCK

Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System

15 8 2023 07:30:00 提供 Nasdaq GlobeNewswire

Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board

10 8 2023 07:30:00 提供 Nasdaq GlobeNewswire

Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe

25 7 2023 08:23:35 提供 Nasdaq GlobeNewswire

Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board

11 7 2023 07:30:00 提供 Nasdaq GlobeNewswire

Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US

29 6 2023 07:30:00 提供 Nasdaq GlobeNewswire

Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings

28 6 2023 13:05:41 提供 Nasdaq GlobeNewswire

Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

27 6 2023 07:00:01 提供 Nasdaq GlobeNewswire

Microbot Medical Expand IP protection in Japan

22 6 2023 07:36:38 提供 Nasdaq GlobeNewswire

Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe

16 6 2023 07:30:00 提供 Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

06 6 2023 11:33:23 提供 Nasdaq GlobeNewswire

Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

02 6 2023 11:36:53 提供 Nasdaq GlobeNewswire

Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System

02 6 2023 07:16:15 提供 Nasdaq GlobeNewswire

LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process

31 5 2023 07:30:00 提供 Nasdaq GlobeNewswire

Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human Trial

25 5 2023 07:40:00 提供 Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

24 5 2023 12:05:00 提供 Nasdaq GlobeNewswire

Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

23 5 2023 14:24:08 提供 Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

23 5 2023 12:41:00 提供 Nasdaq GlobeNewswire

Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

22 5 2023 14:18:00 提供 Nasdaq GlobeNewswire

Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians

22 5 2023 07:30:00 提供 Nasdaq GlobeNewswire

Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases

18 5 2023 08:15:00 提供 Nasdaq GlobeNewswire